Teva Pharmaceutical Industries (TEVJF) FCF Payout Ratio (2017 - 2018)
Teva Pharmaceutical Industries (TEVJF) recorded quarterly FCF Payout Ratio of 0.01 in Q4 2018, down 283.12% on a QoQ basis from 0.01 in Q3 2018.
Teva Pharmaceutical Industries (TEVJF) FCF Payout Ratio (2017 - 2018) Analysis & Trends
Teva Pharmaceutical Industries has disclosed FCF Payout Ratio across 2 years of filings, most recently posting 0.01 for Q4 2018.
- Quarterly FCF Payout Ratio changed N/A year-over-year to 0.01 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 0.01 (down 80.19% YoY) and the FY2019 annual result came in at 0.23, up 4085.65% from the prior year.
- FCF Payout Ratio declined to 0.01 in Q4 2018, from 0.01 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 1.43 in Q2 2017 and troughed at 5.24 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.77 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Teva Pharmaceutical Industries | - | - | 1.97 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -0.01 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | -0.08 |
| Mar 31, 2018 | 0.01 |
| Sep 30, 2017 | -1.12 |
| Jun 30, 2017 | 1.43 |
| Mar 31, 2017 | -5.24 |